Investor profile
Sean Parker
Angel, Operator angel & Founder, Chairman at Parker Institute for Cancer Immunotherapy
Sean Parker is an angel investor and operator angel based in Los Angeles, California, United States. The known portfolio counts 11 companies: Spotify, OpenFan, Osaro, Airtime, Nura, WillCall, ByHeart, Thrive Global, RevUp Software, 3T Biosciences and IgGenix.
Is Sean Parker a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Seed
- Sector
- AIConsumerHealthcare
Contacts
Sean Parker portfolio companies (11)
- Spotify
- OpenFan
- Osaro
- Airtime
- Nura
- WillCall
- ByHeart
- Thrive Global
- RevUp Software
- 3T Biosciences
- IgGenix
Affiliated funds' portfolios
Founder, Chairman at Parker Institute for Cancer Immunotherapy, whose known portfolio counts 8 companies
- ArsenalBio
- Senti Biosciences
- Azalea Therapeutics
- Xaira Therapeutics
- Georgiamune
- Affini-T Therapeutics
- Dispatch Bio
- Akamis Bio
Investor Profile
Founders in the listed sectors AI, Consumer and Healthcare, and focus areas Biotech, Consumer Internet, Digital Health and Generative AI will recognize the pattern in this portfolio.
Stage-wise, the known deals cluster around Seed rounds.
The portfolio and focus above give founders context on whether Sean Parker matches their raise.
Colleagues at Parker Institute for Cancer Immunotherapy
Similar investors
Showing 20 of 100
Frequently asked questions
Who is Sean Parker?
Sean Parker is an angel investor and operator angel based in Los Angeles, California, United States with 11 known investments on file, among them Spotify, OpenFan and Osaro. The sections above list the sectors, stages and firms attached to that record.
What does Sean Parker invest in?
Listed sectors include AI, Consumer and Healthcare; listed focus areas include Biotech, Consumer Internet, Digital Health and Generative AI. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Sean Parker invest at?
The known deals of Sean Parker include Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Sean Parker listed at?
Sean Parker is listed as Founder, Chairman at Parker Institute for Cancer Immunotherapy. One other person in the database shares a firm with Sean Parker.
How do I contact Sean Parker?
An email address and a LinkedIn page are on file for Sean Parker. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
